Current Report Filing (8-k)
December 02 2022 - 06:06AM
Edgar (US Regulatory)
0001497130 false 0001497130 2022-11-02
2022-11-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (Date of earliest event reported):
November 2, 2022
NANO MOBILE HEALTHCARE, INC.
(Exact Name
of Registrant as Specified in its Charter)
Nevada
(State or other jurisdiction
of incorporation) |
000-55155
(Commission
File Number) |
98-0659770
(I.R.S. Employer
Identification No.) |
370 Ampola Ave.,
Suite 200-A
Torrance,
CA
90501
(Address of Principal Executive Offices and Zip
Code)
Registrant’s
telephone number, including area code:
(424)
358-1046
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
|
☐ |
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Indicate by
check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
|
Title of each class |
Trading
Symbol(s)
|
Name of each exchange on which registered |
|
Common Stock, par value of $0.00001 |
VNTH |
OTCMKTS |
|
Item
4.01 |
Changes
in Registrant’s Certifying Accountant |
On
November 2, 2022 the Registrant engaged Haroon Imtiaz, CPA as the
Registrant's new independent registered public accounting firm. The
appointment of Haroon Imtiaz, CPA was approved by the Board of
Directors of Nano Mobile Healthcare, Inc.. Haroon Imtiaz, CPAwill
be reviewing and providing audit services related to the financial
statements that are to be included in the Annual Report for the
period ended December 31, 2021. Haroon Imtiaz, CPA did not prepare
or provide any financial reports for any periods prior to the date
of engagement, nor did it prepare or provide any financial reports
for, or prior to the year ended December 31, 2021. Neither the
Company, nor any person on behalf of the Company, consulted with
Haroon Imtiaz, CPA during the Company's two most recent fiscal
years or the subsequent interim period prior to the engagement of
Haroon Imtiaz, CPA.
Item 9.01.
Financial
Statements and Exhibits.
Exhibit
No.
10.1
Audit Report
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
NANO MOBILE
HEALTHCARE, INC.
| Date:
December 1, 2022 |
By: /s/ Adam
Matruski |
| |
Name: |
Adam
Matruski |
| |
Title: |
Chairman,
President and CEO |
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From May 2023 to Jun 2023
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jun 2022 to Jun 2023
